| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Dez―23 |
Longer-term outcomes after molnupiravir for COVID-19 |
|
| 2 |
[GO] |
2024―Sep―25 |
Intravenous vitamin C for COVID-19: no benefit |
|
| 3 |
[GO] |
2023―Apr―17 |
Molnupiravir provides little benefit in vaccinated adults with COVID-19 |
|
| 4 |
[GO] |
2022―Okt―24 |
Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir |
|
| 5 |
[GO] |
2022―Okt―19 |
Effect of interrupting methotrexate treatment on COVID-19 booster vaccine response |
|
| 6 |
[GO] |
2022―Jan―31 |
Molnupiravir in unvaccinated patients with COVID-19 |
|
| 7 |
[GO] |
2021―Apr―30 |
COVID-19 vaccination in pregnancy |
Joanna Girling |
| 8 |
[GO] |
2020―Dez―02 |
Covid-19 vaccination-we need more than the ‘mum test’ |
David Phizackerley |
| 9 |
[GO] |
2020―Jul―20 |
Dexamethasone for COVID-19: preliminary findings |
|
| 10 |
[GO] |
2020―Mai―27 |
Deprescribing in the time of covid-19 |
David Phizackerley |
| 11 |
[GO] |
2020―Mai―25 |
COVID-19: has EBM been replaced by hype-based medicine? |
Margaret McCartney |
| 12 |
[GO] |
2020―Mai―18 |
More advice on the use of ibuprofen for COVID-19 |
|
| 13 |
[GO] |
2020―Apr―15 |
EMA advice on renin-angiotensin system medicines during covid-19 pandemic |
|
| 14 |
[GO] |
2020―Mrz―31 |
EMA advice on the use of NSAIDs for Covid-19 |
|
